Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.

Vasc Health Risk Manag · 2008 · PMC2663445 · PMID 19337550

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The study showed a highly significant reduction of thromboembolic events with increased doses of razaxaban.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.